Vyome Biosciences picks up $14 mln
India-based Vyome Biosciences, which is focused on treating skin diseases caused by resistant microbes, has raised $14 million in Series C financing. Perceptive Advisors and Romulus Capital led the round with participation from other investors that included Kalaari Capital, Sabre Partners and Aarin Capital.
23 August 2016•1 min read
